ESTUDIO DE SEGUIMIENTO ABIERTO Y MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD A LARGO PLAZO DE BRIVARACETAM UTILIZADO COMO TRATAMIENTO COMPLEMENTARIO EN SUJETOS DE 16 AÑOS DE EDAD O MAYORES CON EPILEPSIA.

Datos básicos

Protocolo:
N01379
EUDRACT:
2010-020345-27
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2011
Año de finalización:
2016
ENSAYO CLÍNICO INTERNACIONAL

Objetivos del proyecto

Observaciones: Estado Comité: FINALIZADO

Documentos

  • No hay documentos

Participantes

Financiadores - Promotores

SCHWARTZ BIOSCIENCES, INC-UCB GROUP

Resultados del Ensayo Clínico


Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety

Lagae L; (...); Yang H

Article. 10.1111/epi.13417. 2016


Assessment of the in vivo formation of biofilm on external ventricular drainages.

Ramírez P; (...); Bonastre J

Article. 10.1007/s10096-013-1895-8. 2013


CD4/CD8 ratio in aqueous humor in Uveitis.

Sanz-Marco E; (...); Diaz-Llopis M

Letter. 10.3109/09273948.2013.801993. 2013


Combination of Corpus Callosotomy and Vagus Nerve Stimulation in the Treatment of Refractory Epilepsy

Guillamon, E; (...); Villanueva, V

Article. 10.1159/000353979. 2014


Cost-effectiveness of buccal midazolam in the treatment of prolonged convulsive seizures in the outpatient setting in Spain

Raspall-Chaure, M; (...); Cebollero, MA

Article. 10.33588/rn.5811.2014057. 2014


Drug-resistant epilepsy: Definition and treatment alternatives

Gonzalez, FJL; (...); Cerda, JMM

Review. 10.1016/j.nrl.2014.04.012. 2015

  • Open Access.

Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

Villanueva, V; (...); Saiz-Diaz, RA

Article. 10.1007/s40261-014-0255-5. 2015


Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study

Garces, M; (...); Olmedilla, N

Article. 10.1016/j.yebeh.2014.05.015. 2014


Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

Villanueva, V; (...); Molins, A

Article. 10.1016/j.eplepsyres.2014.04.014. 2014


Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate - Expert opinion

Peltola, J; (...); Villanueva, V

Article. 10.1016/j.yebeh.2015.05.036. 2015


Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

Villanueva, V; (...); Baiges, JJ

Article. 10.1016/j.eplepsyres.2016.08.001. 2016


Spanish MYH7 founder mutation of Italian ancestry causing a large cluster of Laing myopathy patients.

Muelas N; (...); Vílchez JJ

Article. 10.1111/j.1399-0004.2011.01667.x. 2012


Spanish MYH7 founder mutation of Italian ancestry causing a large cluster of Laing myopathy patients.

Muelas, N; (...); Vílchez, JJ

Article. 2012


Uso benzodiacepinas en crisis prolongadas y estado epileptico en la comunidad.

Sanchez-Carpintero R; (...); Cebollero MA

Article. 10.1016/j.anpedi.2014.03.023. 2014


Campos de Estudio

Compartir